GW3965 is a potent and selective LXR agonist, activating human LXRalpha and beta in cell-based reporter gene assays (EC50=190 and 30 nM respectively).1 Since LXR is a master regulator of cholesterol and fatty acid metabolism, GW3965 exerts a variety of effects including antiatherosclerotic2, antiinflammatory3 as well as antinociceptive4 and alteration of fat tissue distribution5. Orally active.
* VAT and and shipping costs not included. Errors and price changes excepted
